애스크로AIPublic Preview
← 학술논문 검색
학술논문Archives of Pharmacal Research2012.01 발행

Life Span Extension of Caenorhabditis elegans by Novel Pyridoperimidine Derivative

Life Span Extension of Caenorhabditis elegans by Novel Pyridoperimidine Derivative

Ahmed A. R. Sayed(Minia University); Kamal M. El-Shaieb(Minia University); Aboul-Fetouh E. Mourad(Minia University)

35권 1호, 69~76쪽

초록

Zwitterions formed from the addition of triphenylphosphine to dialky acetylene-dicarboxylates attack the nucleus of both 1H-perimidine (1) and 1H-benzo[d]imidazole (9) to form novel pyrido[1,2,3-cd]perimidine and imidazo[4,5,1-ij]quinoline derivatives in moderate yields (64-72%). The biological activity of the products has been studied. Compound 3a was found to extend life span of wild type Caenorhabditis elegans under standard laboratory conditions. Both heat stress and induced chemical stress resistance of wild type C. elegans were improved in a reverse dose-dependent manner due to 3a treatment. In addition, treatment of worms with compound 3a significantly attenuated the formation of advanced glycation end products in a reverse dose-dependent manner.

Abstract

Zwitterions formed from the addition of triphenylphosphine to dialky acetylene-dicarboxylates attack the nucleus of both 1H-perimidine (1) and 1H-benzo[d]imidazole (9) to form novel pyrido[1,2,3-cd]perimidine and imidazo[4,5,1-ij]quinoline derivatives in moderate yields (64-72%). The biological activity of the products has been studied. Compound 3a was found to extend life span of wild type Caenorhabditis elegans under standard laboratory conditions. Both heat stress and induced chemical stress resistance of wild type C. elegans were improved in a reverse dose-dependent manner due to 3a treatment. In addition, treatment of worms with compound 3a significantly attenuated the formation of advanced glycation end products in a reverse dose-dependent manner.

발행기관:
대한약학회
분류:
약학

AI 법률 상담

이 논문의 주제에 대해 더 알고 싶으신가요?

460만+ 법률 자료에서 관련 판례·법령·해석례를 찾아 답변합니다

AI 상담 시작
Life Span Extension of Caenorhabditis elegans by Novel Pyridoperimidine Derivative | Archives of Pharmacal Research 2012 | AskLaw | 애스크로 AI